0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Reviews |

Antimicrobial Prophylaxis in Bone Marrow Transplantation

Feroze Momin; and Pranatharthi H. Chandrasekar
[+] Article and Author Information

From Wayne State University, Detroit, Michigan. Requests for Reprints: Pranatharthi H. Chandrasekar, MD, Hematology-Oncology/Infectious Diseases Liaison Unit, Division of Infectious Diseases, Wayne State University School of Medicine, 4160 John R, Suite 2140, Detroit, MI 48201. Acknowledgment: The authors thank Ms. Eileen Surma for expert secretarial assistance.


Copyright ©2004 by the American College of Physicians


Ann Intern Med. 1995;123(3):205-215. doi:10.7326/0003-4819-123-3-199508010-00008
Text Size: A A A

Objective: To review the efficacy of antimicrobial prophylaxis in bone marrow transplantation.

Data Sources: English-language articles identified through a MEDLINE search (1975 to 1994) and through the bibliographies of selected articles.

Study Selection: Articles on the use of antimicrobial agents for the prevention of infections in bone marrow transplant recipients and neutropenic patients with cancer.

Data Synthesis: Use of quinolones reduces the incidence of gram-negative bacillary infections but increases the frequency of infections caused by streptococci and staphylococci before marrow engraftment. Death associated with α-hemolytic streptococcal bacteremia is of concern and may justify the use of penicillin for prophylaxis. Conflicting data exist regarding prophylaxis with vancomycin. Although ganciclovir has diminished the incidence of infection and disease caused by cytomegalovirus in seropositive recipients, drug-induced myelotoxicity, emergence of resistant virus, and cost are major concerns. High-dose acyclovir may suppress reactivation of cytomegalovirus. Acyclovir prevents herpes simplex virus infection, but its prolonged use to prevent reactivation of varicella-zoster virus is not cost-effective and remains controversial. Fluconazole prevents colonization and infection with Candida species other than C. krusei and Torulopsis glabrata before marrow engraftment. Elevation of cyclosporine concentrations because of interaction between azoles and cyclosporine requires close monitoring of plasma drug levels. Optimal chemoprophylaxis is not available against aspergillus or fungal infections that develop after engraftment. Trimethoprim-sulfamethoxazole decreases the incidence of Pneumocystis carinii infection and “late” bacterial infections in recipients of allogeneic transplants who have chronic graft-versus-host disease.

Conclusion: Available antimicrobial agents can prevent common bacterial, viral, and “early” fungal infections. However, the few studies that address antimicrobial prophylaxis in bone marrow transplantation have not always shown a survival benefit. Toxicity and cost-effectiveness of prophylactic strategies should be critically evaluated.

Figures

Grahic Jump Location
Figure 1.
Commonly seen infections by time after bone marrow transplantation.

GVHD = graft-versus-host disease. Adapted from: Meyers JD. Infections in marrow transplant recipients. In: Mandell GL, Douglas RG Jr, Bennett JE, eds. Principles and Practice of Infectious Diseases. 3d ed. New York: Churchill Livingstone; 1990:2291-4.

Grahic Jump Location

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)